{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:47:24Z","timestamp":1793227644685,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Health-related quality of life (HRQoL) is lower in people with NAFLD compared to the general population. Sleep disturbance resulting in daytime sleepiness is common in patients with NAFLD, but the effect of daytime sleepiness on HRQoL in NAFLD is unclear. The prevalence and natural history of NAFLD vary in different ethnic groups, but there has been limited ethnic diversity in HrQoL studies to date. We aimed to assess whether daytime sleepiness is independently associated with reduced HRQoL in an ethnically diverse UK population. We conducted HRQoL assessments using SF-36 version 2 and Epworth Sleepiness Scale (ESS) questionnaires in 192 people with NAFLD. Multivariate linear regression was used to identify factors independently affecting HRQoL scales. People with NAFLD reported significantly reduced physical health-related SF-36 scores compared to the general UK population. South Asian NAFLD patients reported impairment in physical health, but not mental health, approximately a decade before White NAFLD patients. In multivariate linear regression, daytime sleepiness (ESS score\u2009&gt;\u200910), was the most significant independent predictor of reduced physical health. Age, BMI and liver stiffness score were also significantly associated. HRQoL is impaired earlier in patients of South Asian ethnicity. ESS score\u2009&gt;\u200910, indicative of excessive daytime sleepiness, is an independent predictor of reduced HRQoL in people with NAFLD regardless of ethnicity. Daytime sleepiness should be considered as a contributing factor to reduced HRQoL in clinical practice and when evaluating patient-related outcomes in clinical trials.<\/jats:p>","DOI":"10.1038\/s41598-022-08358-y","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T04:39:56Z","timestamp":1648183196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The contribution of daytime sleepiness to impaired quality of life in NAFLD in an ethnically diverse population"],"prefix":"10.1038","volume":"12","author":[{"given":"Wenhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Karl","family":"Kadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Hallimond","family":"Brindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Devalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-kin","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Alazawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"8358_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7861\/clinmed.2020-0696","volume":"20","author":"W Li","year":"2020","unstructured":"Li, W. & Alazawi, W. Non-alcoholic fatty liver disease. Clin. Med. (Northfield. Il) 20, 509\u2013512 (2020).","journal-title":"Clin. Med. (Northfield. Il)"},{"key":"8358_CR2","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt, M. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61, 1547\u20131554 (2015).","journal-title":"Hepatology"},{"key":"8358_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"Research, U. S. D. of H. and H. S. F. D. A. C. for D. E. and, Research, U. S. D. of H. and H. S. F. D. A. C. for B. E. and & Health, U. S. D. of H. and H. S. F. D. A. C. for D. and R","year":"2006","unstructured":"Research, U. S. D. of H. and H. S. F. D. A. C. for D. E. and, Research, U. S. D. of H. and H. S. F. D. A. C. for B. E. and & Health, U. S. D. of H. and H. S. F. D. A. C. for D. and R. Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health Qual. Life Outcomes 4, 79 (2006).","journal-title":"Health Qual. Life Outcomes"},{"key":"8358_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/jech.53.1.46","volume":"53","author":"C Jenkinson","year":"1999","unstructured":"Jenkinson, C., Stewart-Brown, S., Petersen, S. & Paice, C. Assessment of the SF-36 version 2 in the United Kingdom. J. Epidemiol. Community Health 53, 46\u201350 (1999).","journal-title":"J. Epidemiol. Community Health"},{"key":"8358_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0970-0218.106623","volume":"38","author":"R Sinha","year":"2013","unstructured":"Sinha, R., van den Heuvel, W. A. & Arokiasamy, P. Validity and reliability of MOS short form health survey (SF-36) for use in India. Indian J. Community Med. 38, 22 (2013).","journal-title":"Indian J. Community Med."},{"key":"8358_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1186\/s40064-016-2716-1","volume":"5","author":"M Atif","year":"2016","unstructured":"Atif, M. et al. Health-related quality of life and depression among medical sales representatives in Pakistan. Springerplus 5, 1048 (2016).","journal-title":"Springerplus"},{"key":"8358_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jclinepi.2012.05.004","volume":"65","author":"AHM Feroz","year":"2012","unstructured":"Feroz, A. H. M. et al. The Bengali Short Form-36 was acceptable, reliable, and valid in patients with rheumatoid arthritis. J. Clin. Epidemiol. 65, 1227\u20131235 (2012).","journal-title":"J. Clin. Epidemiol."},{"key":"8358_CR8","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/hep.22868","volume":"49","author":"K David","year":"2009","unstructured":"David, K. et al. Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49, 1904\u20131912 (2009).","journal-title":"Hepatology"},{"key":"8358_CR9","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.cgh.2019.02.024","volume":"17","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. et al. Reduced patient-reported outcome scores associate with level of fibrosis in patients with nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol. 17, 2552-2560.e10 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"8358_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.046","author":"N Samala","year":"2020","unstructured":"Samala, N. et al. Decreased quality of life is significantly associated with body composition in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2020.04.046 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"8358_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. Non-alcoholic fatty liver disease\u2014A global public health perspective. J. Hepatol. 70, 531\u2013544 (2019).","journal-title":"J. Hepatol."},{"key":"8358_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.freeradbiomed.2013.08.180","volume":"65","author":"M Quintero","year":"2013","unstructured":"Quintero, M. et al. The effects of intermittent hypoxia on redox status, NF-\u03baB activation, and plasma lipid levels are dependent on the lowest oxygen saturation. Free Radic. Biol. Med. 65, 1143\u20131154 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"8358_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.smrv.2018.01.003","volume":"41","author":"K Hnin","year":"2018","unstructured":"Hnin, K. et al. The impact of ethnicity on the prevalence and severity of obstructive sleep apnea. Sleep Med. Rev. 41, 78\u201386 (2018).","journal-title":"Sleep Med. Rev."},{"key":"8358_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1046\/j.1365-2869.2000.00177.x","volume":"9","author":"MW Johns","year":"2000","unstructured":"Johns, M. W. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: Failure of the MSLT as a gold standard. J. Sleep Res. 9, 5\u201311 (2000).","journal-title":"J. Sleep Res."},{"key":"8358_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"8358_CR16","doi-asserted-by":"crossref","unstructured":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157\u2013163 (2004).","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"8358_CR17","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.4732","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Racial\/ethnic differences in sleep disturbances: The Multi-Ethnic Study of Atherosclerosis (MESA). Sleep https:\/\/doi.org\/10.5665\/sleep.4732 (2015).","journal-title":"Sleep"},{"key":"8358_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.dsx.2016.06.009","volume":"10","author":"S Gupta","year":"2016","unstructured":"Gupta, S. & Wang, Z. Predictors of sleep disorders among patients with type 2 diabetes mellitus. Diabetes Metab. Syndr. Clin. Res. Rev. 10, 213\u2013220 (2016).","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"8358_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.sleep.2020.10.020","volume":"76","author":"Y Fatima","year":"2020","unstructured":"Fatima, Y. et al. Sleep trajectories and mediators of poor sleep: findings from the longitudinal analysis of 41,094 participants of the UK Biobank cohort. Sleep Med. 76, 120\u2013127 (2020).","journal-title":"Sleep Med."},{"key":"8358_CR20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1177\/193229681000400630","volume":"4","author":"M Roopa","year":"2010","unstructured":"Roopa, M., Deepa, M., Indulekha, K. & Mohan, V. Prevalence of sleep abnormalities and their association with metabolic syndrome among Asian Indians: Chennai Urban Rural Epidemiology Study (CURES-67). J. Diabetes Sci. Technol. 4, 1524\u20131531 (2010).","journal-title":"J. Diabetes Sci. Technol."},{"key":"8358_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.5664\/jcsm.2748","volume":"09","author":"N Chirakalwasan","year":"2013","unstructured":"Chirakalwasan, N. et al. Comparison of polysomnographic and clinical presentations and predictors for cardiovascular-related diseases between non-obese and obese obstructive sleep apnea among Asians. J. Clin. Sleep Med. 09, 553\u2013557 (2013).","journal-title":"J. Clin. Sleep Med."},{"key":"8358_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz101","author":"R Barfield","year":"2019","unstructured":"Barfield, R. et al. Epigenome-wide association analysis of daytime sleepiness in the Multi-Ethnic Study of Atherosclerosis reveals African-American-specific associations. Sleep https:\/\/doi.org\/10.1093\/sleep\/zsz101 (2019).","journal-title":"Sleep"},{"key":"8358_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1440-1843.2001.00325.x","volume":"6","author":"D Ito","year":"2001","unstructured":"Ito, D., Akashiba, T., Yamamoto, H., Kosaka, N. & Horie, T. Craniofacial abnormalities in Japanese patients with severe obstructive sleep apnoea syndrome. Respirology 6, 157\u2013161 (2001).","journal-title":"Respirology"},{"key":"8358_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1183\/09031936.99.13240399","volume":"13","author":"H Sakakibara","year":"1999","unstructured":"Sakakibara, H. et al. Cephalometric abnormalities in non-obese and obese patients with obstructive sleep apnoea. Eur. Respir. J. 13, 403\u2013410 (1999).","journal-title":"Eur. Respir. J."},{"key":"8358_CR25","doi-asserted-by":"publisher","first-page":"e000069","DOI":"10.1136\/bmjgast-2015-000069","volume":"3","author":"KS Chawla","year":"2016","unstructured":"Chawla, K. S. et al. Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH). BMJ Open Gastroenterol. 3, e000069 (2016).","journal-title":"BMJ Open Gastroenterol."},{"key":"8358_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.14309\/ajg.0000000000000375","volume":"114","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. et al. Patients with nonalcoholic steatohepatitis experience severe impairment of health-related quality of life. Am. J. Gastroenterol. 114, 1636\u20131641 (2019).","journal-title":"Am. J. Gastroenterol."},{"key":"8358_CR27","doi-asserted-by":"publisher","first-page":"e000106","DOI":"10.1136\/bmjgast-2016-000106","volume":"3","author":"M Sayiner","year":"2016","unstructured":"Sayiner, M. et al. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease. BMJ Open Gastroenterol. 3, e000106 (2016).","journal-title":"BMJ Open Gastroenterol."},{"key":"8358_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gut.2007.139303","volume":"57","author":"JL Newton","year":"2008","unstructured":"Newton, J. L. et al. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 57, 807\u2013813 (2008).","journal-title":"Gut"},{"key":"8358_CR29","doi-asserted-by":"publisher","first-page":"e0143293","DOI":"10.1371\/journal.pone.0143293","volume":"10","author":"C Bernsmeier","year":"2015","unstructured":"Bernsmeier, C. et al. Sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease: A comparison with healthy controls. PLoS ONE 10, e0143293 (2015).","journal-title":"PLoS ONE"},{"key":"8358_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S2213-2600(19)30402-3","volume":"8","author":"AJ Wimms","year":"2020","unstructured":"Wimms, A. J. et al. Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): A multicentre, randomised controlled trial. Lancet Respir. Med. 8, 349\u2013358 (2020).","journal-title":"Lancet Respir. Med."},{"key":"8358_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/archinte.163.5.565","volume":"163","author":"SR Patel","year":"2003","unstructured":"Patel, S. R., White, D. P., Malhotra, A., Stanchina, M. L. & Ayas, N. T. Continuous positive airway pressure therapy for treating gess in a diverse population with obstructive sleep apnea. Arch. Intern. Med. 163, 565 (2003).","journal-title":"Arch. Intern. Med."},{"key":"8358_CR32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-1868OC","author":"SS Ng","year":"2020","unstructured":"Ng, S. S. et al. CPAP did not improve nonalcoholic fatty liver disease in patients with obstructive sleep apnea: A randomized clinical trial. Am. J. Respir. Crit. Care Med. https:\/\/doi.org\/10.1164\/rccm.202005-1868OC (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"8358_CR33","doi-asserted-by":"publisher","first-page":"e96349","DOI":"10.1371\/journal.pone.0096349","volume":"9","author":"EA Pulixi","year":"2014","unstructured":"Pulixi, E. A. et al. Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease. PLoS ONE 9, e96349 (2014).","journal-title":"PLoS ONE"},{"key":"8358_CR34","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.3399\/bjgp14X682273","volume":"64","author":"W Alazawi","year":"2014","unstructured":"Alazawi, W. et al. Ethnicity and the diagnosis gap in liver disease: A population-based study. Br. J. Gen. Pract. 64, e694\u2013e702 (2014).","journal-title":"Br. J. Gen. Pract."},{"key":"8358_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/NMD.0b013e31816ff3bf","volume":"196","author":"LD Rosenthal","year":"2008","unstructured":"Rosenthal, L. D. & Dolan, D. C. The Epworth Sleepiness Scale in the identification of obstructive sleep apnea. J. Nerv. Ment. Dis. 196, 429\u2013431 (2008).","journal-title":"J. Nerv. Ment. Dis."},{"key":"8358_CR36","first-page":"P2286","volume":"44","author":"H Puretic","year":"2014","unstructured":"Puretic, H. et al. The Epworth sleepiness scale 23 years after: Is daytime sleepiness still a valid screening tool for sleep apnea. Eur. Respir. J. 44, P2286 (2014).","journal-title":"Eur. Respir. J."},{"key":"8358_CR37","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675\u20131685 (2010).","journal-title":"N. Engl. J. Med."},{"key":"8358_CR38","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/liv.13706","volume":"38","author":"ZM Younossi","year":"2018","unstructured":"Younossi, Z. M. et al. Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. Liver Int. 38, 1849\u20131859 (2018).","journal-title":"Liver Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08358-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:01:12Z","timestamp":1669338072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08358-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8358"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08358-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5123"}}